Cerus Corporation (CERS) Key Metrics

NASDAQ: CERSValuation, returns, debt and efficiency ratios over 10 years.

CERS valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$439.3M
Enterprise value
$544.5M
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
2.0
10-yr median 8.2
Price / book
7.5
10-yr median 8.6
EV / EBITDA
187.2
Dividend yield
—
Beta
1.83

CERS key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

CERS valuation Price multiples at each fiscal year-end price.

Price / sales+20.8%
1.9
2025 · hover or tap a bar for each year
2016: 11.9 (−33.4%)2017: 8.4 (−29.5%)2018: 11.0 (+30.5%)2019: 7.9 (−27.9%)2020: 12.3 (+56.1%)2021: 8.9 (−27.8%)2022: 4.0 (−55.4%)2023: 2.5 (−37.4%)2024: 1.6 (−36.7%)2025: 1.9 (+20.8%)
20162025
Price / book+20.8%
6.1
2025 · hover or tap a bar for each year
2016: 7.7 (+18.6%)2017: 9.4 (+22.6%)2018: 7.9 (−15.9%)2019: 10.3 (+31.0%)2020: 10.9 (+5.7%)2021: 13.8 (+26.1%)2022: 9.5 (−30.9%)2023: 7.4 (−22.4%)2024: 5.1 (−31.5%)2025: 6.1 (+20.8%)
20162025
Price / free cash flow+38.1%
46.1
2025 · hover or tap a bar for each year
2024: 33.42025: 46.1 (+38.1%)
20162025
Free cash flow yield−0.8 pts
2.2%
2025 · hover or tap a bar for each year
2016: −12.2% (−3.7 pts)2017: −14.4% (−2.2 pts)2018: −4.9% (+9.5 pts)2019: −12.6% (−7.8 pts)2020: −3.8% (+8.8 pts)2021: −3.0% (+0.8 pts)2022: −4.3% (−1.3 pts)2023: −12.3% (−8.0 pts)2024: 3.0% (+15.3 pts)2025: 2.2% (−0.8 pts)
20162025

CERS valuation history

Fiscal year-endToday10-year median

CERS returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

CERS debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

CERS cash returned to shareholders

DividendsBuybacksFree cash flow

CERS price vs earnings per share

Share price at year-endEPS (right axis)

CERS key metrics

2016–2025
Cerus Corporation key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$392.6M$284.2M$389.4M$644.4M$1.17B$1.13B$590.1M$667.5M$365.8M$442.9M
Enterprise value$406.7M$301.9M$419.5M$629.5M$1.12B$1.07B$568.8M$579.8M$346.6M$390.7M
Price / sales1.91.62.54.08.912.37.911.08.411.9
Price / book6.15.17.49.513.810.910.37.99.47.7
Price / free cash flow46.133.4————————
Price / operating cash flow34.625.0————————
EV / sales2.01.72.73.98.611.67.69.58.010.5
EV / free cash flow47.735.4————————
Earnings yield−4.0%−7.4%−9.6%−6.6%−4.7%−5.3%−12.1%−8.6%−16.6%−14.2%
Free cash flow yield2.2%3.0%−12.3%−4.3%−3.0%−3.8%−12.6%−4.9%−14.4%−12.2%
Dividend yield——2.7%0.7%————0.0%0.0%
Shareholder yield (dividends + buybacks)——2.7%0.7%0.0%0.0%0.0%0.0%0.0%0.0%
Share price at fiscal year-end$2.06$1.54$2.16$3.65$6.81$6.92$4.22$5.07$3.38$4.35
Per share
Revenue per share$1.08$0.98$0.87$0.92$0.76$0.56$0.53$0.46$0.40$0.37
Earnings per share−$0.08−$0.11−$0.21−$0.24−$0.32−$0.37−$0.51−$0.44−$0.56−$0.62
Operating cash flow per share$0.06$0.06−$0.24−$0.15−$0.20−$0.26−$0.47−$0.24−$0.48−$0.53
Free cash flow per share$0.04$0.05−$0.26−$0.16−$0.20−$0.26−$0.53−$0.25−$0.49−$0.53
Cash per share$0.43$0.44$0.37$0.58$0.76$0.81$0.61$0.89$0.56$0.70
Book value per share$0.34$0.30$0.29$0.38$0.49$0.63$0.41$0.64$0.36$0.57
Tangible book value per share$0.33$0.30$0.28$0.38$0.49$0.63$0.40$0.63$0.34$0.55
Dividends per share——$0.06$0.02————$0.00$0.00
Capex per share$0.01$0.02$0.03$0.01$0.01$0.01$0.06$0.01$0.00$0.01
Debt per share$0.51$0.53$0.53$0.49$0.51$0.41$0.46$0.23$0.38$0.19
Shares outstanding190.6M184.6M180.3M176.5M171.3M163.9M139.8M131.7M108.2M101.8M
Change in shares outstanding+3.3%+2.4%+2.1%+3.1%+4.5%+17.2%+6.2%+21.7%+6.3%+5.1%
Returns & profitability
Return on equity (ROE)−26.0%−38.5%−62.3%−56.3%−57.7%−74.4%−100.6%−93.3%−125.3%−82.5%
Return on invested capital (ROIC)−9.0%−14.4%−35.0%−56.4%−96.7%−126.4%−321.0%—−359.4%−789.8%
Return on assets (ROA)−7.4%−10.5%−18.0%−18.8%−23.7%−30.9%−43.3%−44.0%−60.1%−51.8%
Return on tangible assets−7.1%−10.5%−19.1%−19.8%−23.0%−27.2%−43.4%−35.6%−62.9%−62.0%
Free cash flow margin4.1%4.7%−30.5%−17.0%−26.6%−47.2%−99.7%−53.2%−120.7%−145.5%
Financial health
Total debt$96.9M$98.1M$96.0M$87.2M$87.6M$66.9M$64.5M$29.9M$41.5M$19.4M
Cash & short-term investments$82.9M$80.5M$65.9M$102.2M$129.4M$133.6M$85.7M$117.6M$60.7M$71.6M
Net debt$14.1M$17.6M$30.1M−$14.9M−$41.8M−$66.7M−$21.3M−$87.7M−$19.2M−$52.3M
Debt / equity1.511.751.821.291.040.641.130.351.070.34
Debt / assets0.440.490.490.400.370.300.390.180.420.19
Current ratio1.732.392.141.452.383.062.552.793.893.50
Quick ratio1.171.791.551.212.042.672.162.533.263.03
Interest coverage-1.0-1.6-3.6-5.8-9.9-15.6-10.9-13.7-19.0-25.1
Working capital$73.6M$88.4M$76.9M$53.1M$108.5M$123.5M$77.8M$94.2M$66.8M$67.2M
Invested capital$78.3M$73.8M$82.8M$52.7M$42.8M$37.1M$35.8M−$3.2M$19.8M$5.5M
Tangible asset value$63.6M$55.6M$52.1M$67.2M$84.3M$102.5M$55.6M$82.9M$37.1M$55.7M
Net current asset value$17.5M$8.0M$137,000$20.6M$35.2M$65.8M$19.6M$68.0M$30.6M$48.4M
Graham net-net per share−$0.12−$0.12−$0.18−$0.04$0.06$0.27−$0.00$0.39$0.17$0.37
Capital allocation
Dividends paid——$10.5M$4.2M————$0$0
Share buybacks (net)——$175,000$104,000$0$0$0$0$0$0
Capex / revenue1.4%1.6%2.9%1.2%0.7%1.8%12.0%1.9%0.8%1.5%
Capex / operating cash flow25.0%25.0%————————
Capex / depreciation1.991.531.770.670.290.523.720.790.190.31
Stock-based compensation / revenue11.1%12.7%13.0%15.1%18.0%19.6%17.8%17.1%21.5%21.7%
R&D / revenue32.9%32.7%43.3%39.6%48.7%70.1%80.9%69.9%77.4%84.2%
SG&A / revenue39.3%42.1%52.1%51.4%62.1%72.9%88.7%93.3%120.3%131.1%
Efficiency
Days sales outstanding53.366.181.667.164.675.562.763.480.862.1
Days of inventory on hand183.3176.3179.6135.9143.9189.5180.4161.5218.6209.9
Days payables outstanding96.7102.9148.3167.1172.0205.7222.7238.2253.3124.1
Cash conversion cycle (days)139.9139.5113.035.936.559.320.3-13.246.1147.9
Receivables turnover6.855.524.475.445.654.835.825.754.525.87
Payables turnover3.783.552.462.182.121.771.641.531.442.94
Inventory turnover1.992.072.032.692.541.932.022.261.671.74
Asset turnover0.980.900.750.710.570.480.450.470.430.31
Average receivables$30.1M$32.6M$35.0M$29.8M$23.1M$19.0M$12.8M$10.6M$9.6M$6.3M
Average payables$24.9M$22.8M$28.4M$34.3M$29.9M$23.2M$20.4M$20.6M$15.6M$6.9M
Average inventory$47.1M$39.0M$34.4M$27.9M$25.0M$21.4M$16.5M$14.0M$13.5M$11.7M
Intangibles / total assets0.6%0.7%0.7%0.6%0.6%0.6%0.9%1.0%1.9%2.0%

Computed from CERS's annual financial statements (latest annual report filed March 2, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

CERS valuation and financial ratios

Cerus earned a return on equity of −26.0% and a return on invested capital of −9.0% in fiscal 2025. It ended the year with $96.9 million of debt and $82.9 million in cash and short-term investments, net debt of $14.1 million. The share count rose 87.2% from 101.8M to 190.6M over 9 years.

See the CERS income statement, the CERS chart for price history, or the CERS stock overview for the latest quote and news.

CERS key metrics FAQ

What is Cerus's return on equity?

Cerus's return on equity (ROE) was −26.0% in fiscal 2025: net income of -$15.6 million on average shareholders' equity of $60.2 million.

What is Cerus's ROIC?

Cerus's return on invested capital was −9.0% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Cerus have?

Cerus had total debt of $96.9 million at the end of fiscal 2025, a debt-to-equity ratio of 1.51.

What is Cerus's free cash flow yield?

Cerus generated $8.5 million of free cash flow in fiscal 2025, a free cash flow yield of 2.2% on its market value at year-end ($392.6 million).

What is Cerus's current ratio?

Cerus's current ratio was 1.73 at the end of fiscal 2025: current assets were 1.73 times current liabilities.

Medical Devices key metrics